Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets - PubMed
- ️Thu Jan 01 2004
Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets
Andreas Schober et al. Circ Res. 2004.
Abstract
Monocyte chemoattractant protein-1 (also known as CC chemokine ligand 2 [CCL2]) and its receptor CC chemokine receptor 2 (CCR2) play a central role in the inflammatory response and neointimal formation after vascular injury. In the context of hyperlipidemia, this appears to involve neointimal monocyte infiltration. Hence, we investigated the function of the CCL2/CCR2 axis in early monocyte recruitment to injured arteries. Wire-induced injury of the carotid artery in apoE-/- mice caused a rapid increase of JE/CCL2 protein in the vessel wall peaking at 24 hours after injury, whereas serum JE/CCL2 was increased solely at 6 hours and blood cell-associated levels were unaltered, as demonstrated by enzyme-linked immunosorbent assay. Immunohistochemistry revealed intense staining for JE/CCL2 in smooth muscle cells (SMCs) and in association with platelets adherent to the denuded vessel wall 24 hours after injury. In vitro, exogenous or SMC-derived JE/CCL2 binds to the platelet surface and triggers monocyte arrest on adherent platelets but not on SMCs in flow assays. Accordingly, monocyte arrest in ex vivo perfused apoE-/- carotid arteries isolated 24 hours after injury was profoundly inhibited by pretreatment with a JE/CCL2 antibody. In CCR2-/-/apoE-/- mice, neointimal plaque area was reduced by 47% compared with CCR2+/+/apoE-/- mice. Moreover, CCR2 deletion markedly decreased neointimal macrophage content while expanding SMC content. Vascular JE/CCL2 expressed by SMCs and immobilized by adherent platelets after endothelial denudation is crucial for mediating early monocyte recruitment to injured arteries in hyperlipidemic mice. This mechanism may explain reduced neointimal macrophage infiltration and lesion formation in CCR2-deficient apoE-/- mice.
Similar articles
-
Schober A, Knarren S, Lietz M, Lin EA, Weber C. Schober A, et al. Circulation. 2003 Nov 18;108(20):2491-7. doi: 10.1161/01.CIR.0000099508.76665.9A. Epub 2003 Oct 27. Circulation. 2003. PMID: 14581398
-
Zernecke A, Liehn EA, Fraemohs L, von Hundelshausen P, Koenen RR, Corada M, Dejana E, Weber C. Zernecke A, et al. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):e10-3. doi: 10.1161/01.ATV.0000197852.24529.4f. Epub 2005 Nov 23. Arterioscler Thromb Vasc Biol. 2006. PMID: 16306427
-
Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury.
Wang K, Zhou X, Zhou Z, Mal N, Fan L, Zhang M, Lincoff AM, Plow EF, Topol EJ, Penn MS. Wang K, et al. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1584-9. doi: 10.1161/01.ATV.0000172687.01179.d4. Epub 2005 Jun 9. Arterioscler Thromb Vasc Biol. 2005. PMID: 15947246
-
Chemokines in the pathogenesis of vascular disease.
Charo IF, Taubman MB. Charo IF, et al. Circ Res. 2004 Oct 29;95(9):858-66. doi: 10.1161/01.RES.0000146672.10582.17. Circ Res. 2004. PMID: 15514167 Review.
-
Chemokines in vascular remodeling.
Schober A, Zernecke A. Schober A, et al. Thromb Haemost. 2007 May;97(5):730-7. Thromb Haemost. 2007. PMID: 17479183 Review.
Cited by
-
Response of vascular mesenchymal stem/progenitor cells to hyperlipidemia.
Chen T, Wu Y, Gu W, Xu Q. Chen T, et al. Cell Mol Life Sci. 2018 Nov;75(22):4079-4091. doi: 10.1007/s00018-018-2859-z. Epub 2018 Jun 26. Cell Mol Life Sci. 2018. PMID: 29946805 Free PMC article. Review.
-
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma.
Casari M, Siegl D, Deppermann C, Schuppan D. Casari M, et al. Front Immunol. 2023 Dec 5;14:1277808. doi: 10.3389/fimmu.2023.1277808. eCollection 2023. Front Immunol. 2023. PMID: 38116017 Free PMC article. Review.
-
Chemokine-like functions of MIF in atherosclerosis.
Schober A, Bernhagen J, Weber C. Schober A, et al. J Mol Med (Berl). 2008 Jul;86(7):761-70. doi: 10.1007/s00109-008-0334-2. Epub 2008 Apr 2. J Mol Med (Berl). 2008. PMID: 18385967 Review.
-
Soehnlein O, Drechsler M, Döring Y, Lievens D, Hartwig H, Kemmerich K, Ortega-Gómez A, Mandl M, Vijayan S, Projahn D, Garlichs CD, Koenen RR, Hristov M, Lutgens E, Zernecke A, Weber C. Soehnlein O, et al. EMBO Mol Med. 2013 Mar;5(3):471-81. doi: 10.1002/emmm.201201717. Epub 2013 Feb 18. EMBO Mol Med. 2013. PMID: 23417922 Free PMC article.
-
Engel D, Dobrindt U, Tittel A, Peters P, Maurer J, Gütgemann I, Kaissling B, Kuziel W, Jung S, Kurts C. Engel D, et al. Infect Immun. 2006 Nov;74(11):6100-7. doi: 10.1128/IAI.00881-06. Epub 2006 Sep 11. Infect Immun. 2006. PMID: 16966414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous